Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - NetShares Issued
Ratios

Guided Therapeutics (GTHP) Revenue (Gross) (2023 - 2024)

Guided Therapeutics (GTHP) has disclosed Revenue (Gross) for 2 consecutive years, with $3000.0 as the latest value for Q1 2024.

  • Quarterly Revenue (Gross) changed N/A to $3000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Dec 2024, down 50.0% year-over-year, with the annual reading at $3000.0 for FY2024, 50.0% down from the prior year.
  • Revenue (Gross) hit $3000.0 in Q1 2024 for Guided Therapeutics, down from $6000.0 in the prior quarter.
  • In the past five years, Revenue (Gross) ranged from a high of $6000.0 in Q4 2023 to a low of $3000.0 in Q1 2024.